标题
Potential of cannabinoids as treatments for autism spectrum disorders
作者
关键词
Autism spectrum disorders, Cannabinoids
出版物
JOURNAL OF PSYCHIATRIC RESEARCH
Volume 137, Issue -, Pages 194-201
出版商
Elsevier BV
发表日期
2021-02-27
DOI
10.1016/j.jpsychires.2021.02.048
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lower circulating endocannabinoid levels in children with autism spectrum disorder
- (2019) Adi Aran et al. Molecular Autism
- Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice
- (2019) Erica Zamberletti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment
- (2019) Marika Premoli et al. LIFE SCIENCES
- Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism
- (2019) Han-Fang Wu et al. NEUROPHARMACOLOGY
- Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder
- (2019) Rafael Guimarães Dos Santos et al. CNS DRUGS
- Sex specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling
- (2018) Francesca Melancia et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Plasma anandamide concentrations are lower in children with autism spectrum disorder
- (2018) Debra S. Karhson et al. Molecular Autism
- Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
- (2018) Sara Anna Bonini et al. JOURNAL OF ETHNOPHARMACOLOGY
- Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome
- (2018) Daniele Vigli et al. NEUROPHARMACOLOGY
- Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism
- (2018) Suzanne Hosie et al. Frontiers in Cellular Neuroscience
- Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
- (2018) Shani Poleg et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabinoids for epilepsy: What do we know and where do we go?
- (2017) Martin J. Brodie et al. EPILEPSIA
- The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum
- (2017) Giuseppina Martella et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
- (2017) Erica Zamberletti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
- (2017) Anna Brigida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Examining bidirectional effects between the autism spectrum disorder (ASD) core symptom domains and anxiety in children with ASD
- (2017) Jorieke Duvekot et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Genetics implicate common mechanisms in autism and schizophrenia: synaptic activity and immunity
- (2017) Xiaoming Liu et al. JOURNAL OF MEDICAL GENETICS
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological Foundations of Cannabis Chemovars
- (2017) Mark Lewis et al. PLANTA MEDICA
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serotonin neuron abnormalities in the BTBR mouse model of autism
- (2016) Yue-Ping Guo et al. Autism Research
- Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
- (2016) V.M. Doenni et al. BRAIN BEHAVIOR AND IMMUNITY
- Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11
- (2016) Ellen Doernberg et al. CNS SPECTRUMS
- Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis
- (2016) L. K. Fung et al. PEDIATRICS
- Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
- (2016) M Servadio et al. Translational Psychiatry
- Treatment Resistant Epilepsy in Autism Spectrum Disorder: Increased Risk for Females
- (2015) Karen Blackmon et al. Autism Research
- The role of cannabinoids in adult neurogenesis
- (2015) Jack A Prenderville et al. BRITISH JOURNAL OF PHARMACOLOGY
- Autism and behavior in adult patients with Dravet syndrome (DS)
- (2015) J.J.L. Berkvens et al. EPILEPSY & BEHAVIOR
- Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
- (2015) Guy A. Cabral et al. Journal of Neuroimmune Pharmacology
- Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma
- (2015) Marjannie Eloi Akintunde et al. JOURNAL OF NEUROIMMUNOLOGY
- Immune mediators in the brain and peripheral tissues in autism spectrum disorder
- (2015) Myka L. Estes et al. NATURE REVIEWS NEUROSCIENCE
- Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders
- (2015) Sacha B. Nelson et al. NEURON
- An Overview of Products and Bias in Research
- (2015) David Gloss Neurotherapeutics
- Endocannabinoid Signaling in Autism
- (2015) Bhismadev Chakrabarti et al. Neurotherapeutics
- Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling
- (2015) Haley E. Speed et al. PLoS One
- Endocannabinoid signaling mediates oxytocin-driven social reward
- (2015) Don Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics
- (2015) Genoveva Uzunova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Role of Epigenetic Change in Autism Spectrum Disorders
- (2015) Yuk Jing Loke et al. Frontiers in Neurology
- Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
- (2014) Fabio Arturo Iannotti et al. ACS Chemical Neuroscience
- Potential cytokine biomarkers in autism spectrum disorders
- (2014) Destanie Rose et al. Biomarkers in Medicine
- Metabolic pathology of autism in relation to redox metabolism
- (2014) Richard E Frye et al. Biomarkers in Medicine
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
- (2014) Dario Siniscalco et al. Journal of Neuroinflammation
- Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
- (2014) A Masi et al. MOLECULAR PSYCHIATRY
- The epidemiology and global burden of autism spectrum disorders
- (2014) A. J. Baxter et al. PSYCHOLOGICAL MEDICINE
- Repetitive Behavior and Restricted Interests in Young Children with Autism: Comparisons with Controls and Stability Over 2 Years
- (2013) Lisa Joseph et al. Autism Research
- Alterations in the endocannabinoid system in the rat valproic acid model of autism
- (2013) D.M. Kerr et al. BEHAVIOURAL BRAIN RESEARCH
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1receptor-independent mechanism
- (2013) T D M Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
- (2013) Jakob Christensen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prenatal valproate exposure is associated with autism spectrum disorder and childhood autism
- (2013) Kimford J. Meador et al. JOURNAL OF PEDIATRICS
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
- (2013) Csaba Földy et al. NEURON
- Neonatal levels of cytokines and risk of autism spectrum disorders: An exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank
- (2012) Morsi W. Abdallah et al. JOURNAL OF NEUROIMMUNOLOGY
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
- (2012) Paula E. Goines et al. NEUROTOXICOLOGY AND TERATOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The endocannabinoid system: an overview
- (2012) Natalia Battista et al. Frontiers in Behavioral Neuroscience
- The role of immune dysfunction in the pathophysiology of autism
- (2011) Charity Onore et al. BRAIN BEHAVIOR AND IMMUNITY
- Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders
- (2011) E. S. Onaivi et al. Current Neuropharmacology
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Restricted and repetitive behaviors in autism spectrum disorders: A review of research in the last decade.
- (2011) Susan R. Leekam et al. PSYCHOLOGICAL BULLETIN
- Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces
- (2011) Bhismadev Chakrabarti et al. Molecular Autism
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
- (2010) Paul Ashwood et al. BRAIN BEHAVIOR AND IMMUNITY
- Interaction between cytokines, cannabinoids and the nervous system
- (2010) Lucie Jean-Gilles et al. IMMUNOBIOLOGY
- Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA
- (2010) Mauro Maccarrone et al. NEUROPSYCHOPHARMACOLOGY
- Immune dysfunction in autism: A pathway to treatment
- (2010) Milo Careaga et al. Neurotherapeutics
- Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
- (2010) Chen Li et al. PHARMACOLOGY & THERAPEUTICS
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
- (2009) Balapal Basavarajappa et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation